We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Valeant Pharmaceuticals' fourth-quarter loss widened to $515 million versus $385 million in the same period of 2015, as sales dropped 13 percent year-over-year to $2.4 billion, the company reported Tuesday.
Pfizer received two subpoenas from the US Attorney’s office in Massachusetts related to charities that help Medicare patients afford co-payments for drugs, Bloomberg reported